Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 3
This trial is looking at long term treatment with 2 drugs called olaparib and cediranib for women whose ovarian cancer has started to grow again. It is for women whose cancer shrunk after their first course of chemotherapy. And they are having a second course.
The trial is open to women who have:
ovarian cancer
fallopian tube cancer
primary peritoneal cancer
Doctors treat these cancers in the same way. So, when we use the term ovarian cancer in this summary, we are referring to all 3.
Cancer Research UK supports this trial.
Recruitment start: 15 June 2018
Recruitment end: 15 December 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Shibani Nicum
Cancer Research UK
AstraZeneca
University College London
This is Cancer Research UK trial number CRUK/15/074.
Last reviewed: 15 December 2022
CRUK internal database number: 13388
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
